Kalayeh Kourosh, Fowlkes J Brian, Yeras Sophia, Chen Amy, Daignault-Newton Stephanie, Schultz William W, Sack Bryan S
Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Department of Radiology, University of Michigan, Ann Arbor, MI, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Ultrasound Med Biol. 2024 Oct;50(10):1494-1505. doi: 10.1016/j.ultrasmedbio.2024.05.019. Epub 2024 Jul 25.
The goal of this study was to evaluate the performance of different commercial ultrasound contrast microbubbles (MBs) when measuring bladder phantom pressure with sub-harmonic-aided pressure estimation (SHAPE) methodology. We hypothesized that SHAPE performance is dependent on MB formulation. This study aimed to advance the SHAPE application for bladder pressure measurements in humans.
Using a previously designed and built bladder phantom, we tested four different commercial agents: Definity, Lumason, Sonazoid and Optison. A standard clinical cystometrogram (CMG) system was used to infuse a MB-saline mixture into the bladder phantom to measure pressure. Ultrasound imaging was performed using the GE Healthcare LOGIQ E10 scanner.
All agents showed a predicted inverse linear relationship between change in pressure and SHAPE signal. However, they differ from each other in terms of stability, linear correlation, sensitivity to pressure and error. Generally, Definity and Lumason showed the highest performance during the SHAPE-based bladder phantom pressure assessments.
Our results show that the SHAPE signal decreases as bladder phantom pressures increases, regardless of the agent or CMG phase, suggesting the possibility of using SHAPE for measuring bladder pressure without a catheter. However, the efficacy of SHAPE in measuring pressure varies by MB formulation. These observations support using Lumason and Definity in a human subject feasibility study as we advance toward a catheter-free solution for measuring voiding bladder pressure via SHAPE.
本研究的目的是评估在使用次谐波辅助压力估计(SHAPE)方法测量膀胱模型压力时,不同商用超声造影微泡(MBs)的性能。我们假设SHAPE性能取决于MB的配方。本研究旨在推进SHAPE在人体膀胱压力测量中的应用。
我们使用先前设计和构建的膀胱模型,测试了四种不同的商用制剂:Definity、Lumason、Sonazoid和Optison。使用标准临床膀胱压力图(CMG)系统将MB-盐水混合物注入膀胱模型以测量压力。使用通用电气医疗集团的LOGIQ E10扫描仪进行超声成像。
所有制剂在压力变化与SHAPE信号之间均呈现预期的反向线性关系。然而,它们在稳定性、线性相关性、对压力的敏感性和误差方面彼此不同。总体而言,在基于SHAPE的膀胱模型压力评估中,Definity和Lumason表现出最高的性能。
我们的结果表明,无论使用何种制剂或处于CMG的哪个阶段,随着膀胱模型压力的增加,SHAPE信号都会降低,这表明有可能在不使用导管的情况下使用SHAPE测量膀胱压力。然而,SHAPE测量压力的功效因MB配方而异。随着我们朝着通过SHAPE测量排尿膀胱压力的无导管解决方案迈进,这些观察结果支持在人体可行性研究中使用Lumason和Definity。